Epidermal Growth Factor (EGF) (Middle Region) Peptid
Kurzübersicht für Epidermal Growth Factor (EGF) (Middle Region) Peptid (ABIN8099732)
Target
Quelle
Applikation
-
-
Protein Region
- Middle Region
-
Verwendungszweck
- EGF Peptide - middle region
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Kommentare
-
This is a synthetic peptide designed for use in combination with anti-EGF antibody ( ARP41486_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- EGF (Epidermal Growth Factor (EGF))
-
Hintergrund
-
Background Information: Epidermal growth factor has a profound effect on the differentiation of specific cells in vivo and is a potent mitogenic factor for a variety of cultured cells of both ectodermal and mesodermal origin. The EGF precursor is believed to exist as a membrane-
Alternative Symbols: URG, HOMG4
-
Molekulargewicht
- 6kDa
-
Gen-ID
- 1950
-
NCBI Accession
- NP_001954
-
UniProt
- P01133
Target
-